You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Actinium Pharmaceuticals appoints analytical development director
Mining Exploration Insights – May 2020
Essential Energy Insights - May 14, 2020
Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift
Credit Analytics Case Study: Provogue (India) Limited and Shree Renuka Sugars
Actinium Pharmaceuticals Inc. appointed Jeannine Larrieux director of analytical development.
Larrieux will oversee analytical assay development, biologics license applications and investigational new drug-enabling studies.
Larrieux previously worked as the head of analytical science and technology at Novartis.